share_log

杭州天目山药业股份有限公司关于收到上海证券交易所《关于公司2023年年度报告信息披露问询函》的公告

Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on receiving the Shanghai Stock Exchange's “Inquiry Letter on the Company's 2023 Annual Report Information Disclosure”

SZSI ·  May 13
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more